Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne L Angiolillo
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- University of Connecticut
Farmington, Connecticut, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Children'S Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis, Minnesota, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jul 2008
- Primary completion
- 1 Feb 2011
- Completion
- 31 Mar 2021
- Last update posted
- 27 Apr 2021
- Registered enrollment
- 166
- Registry id
- NCT00671034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.